These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25050814)

  • 1. A unique four-hub protein cluster associates to glioblastoma progression.
    Simeone P; Trerotola M; Urbanella A; Lattanzio R; Ciavardelli D; Di Giuseppe F; Eleuterio E; Sulpizio M; Eusebi V; Pession A; Piantelli M; Alberti S
    PLoS One; 2014; 9(7):e103030. PubMed ID: 25050814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular classification and survival prediction in human gliomas based on proteome analysis.
    Iwadate Y; Sakaida T; Hiwasa T; Nagai Y; Ishikura H; Takiguchi M; Yamaura A
    Cancer Res; 2004 Apr; 64(7):2496-501. PubMed ID: 15059904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of serum proteome alterations in human glioblastoma multiforme.
    Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
    Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.
    Gimenez M; Marie SK; Oba-Shinjo S; Uno M; Izumi C; Oliveira JB; Rosa JC
    BMC Cancer; 2015 Jun; 15():481. PubMed ID: 26108672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic level changes associated with S3I201 treated U87 glioma cells.
    Jain R; Atak A; Yeola A; Srivastava S
    J Proteomics; 2017 Jan; 150():341-350. PubMed ID: 27565396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery: a proteomic approach for brain cancer profiling.
    Khalil AA
    Cancer Sci; 2007 Feb; 98(2):201-13. PubMed ID: 17233837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of gliomas.
    Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
    Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics reveals protein phosphatase 1γ as a biomarker associated with Hippo signal pathway in glioma.
    Xue J; Sang W; Su LP; Gao HX; Cui WL; Abulajiang G; Wang Q; Zhang J; Zhang W
    Pathol Res Pract; 2020 Nov; 216(11):153187. PubMed ID: 32919304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical biopsy identification and grading of gliomas using label-free visible resonance Raman spectroscopy.
    Zhou Y; Liu CH; Wu B; Yu X; Cheng G; Zhu K; Wang K; Zhang C; Zhao M; Zong R; Zhang L; Shi L; Alfano RR
    J Biomed Opt; 2019 Sep; 24(9):1-12. PubMed ID: 31512439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma pathophysiology: insights emerging from proteomics.
    Deighton RF; McGregor R; Kemp J; McCulloch J; Whittle IR
    Brain Pathol; 2010 Jul; 20(4):691-703. PubMed ID: 20175778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of MEOX2 in gliomas.
    Tachon G; Masliantsev K; Rivet P; Petropoulos C; Godet J; Milin S; Wager M; Guichet PO; Karayan-Tapon L
    Mod Pathol; 2019 Jun; 32(6):774-786. PubMed ID: 30659268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.
    Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I
    Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental validation of 5 in-silico predicted glioma biomarkers.
    Towner RA; Jensen RL; Vaillant B; Colman H; Saunders D; Giles CB; Wren JD
    Neuro Oncol; 2013 Dec; 15(12):1625-34. PubMed ID: 24158112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes.
    Thanasupawat T; Glogowska A; Pascoe C; Krishnan SN; Munir M; Begum F; Beiko J; Krcek J; Del Bigio MR; Pitz M; Shen Y; Spicer V; Coombs KM; Wilkins J; Hombach-Klonisch S; Klonisch T
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
    Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
    J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the expression profile of Dickkopf-1 gene in human glioma and the association with tumor malignancy.
    Zhou Y; Liu F; Xu Q; Wang X
    J Exp Clin Cancer Res; 2010 Oct; 29(1):138. PubMed ID: 21029453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of p42.3 in low- and high-grade gliomas.
    Wan W; Xu X; Jia G; Li W; Wang J; Ren T; Wu Z; Zhang J; Zhang L; Lu Y
    World J Surg Oncol; 2014 Jun; 12():185. PubMed ID: 24927751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
    Patil V; Mahalingam K
    Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.